Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Advances in Cancer Research|April 20, 2010
Regulatory T cells in cancerDimitrios Mougiakakos, Aniruddha Choudhury, Alvaro Lladser, et al.
Cancer Research|May 21, 2010
Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-signIsabel Poschke, Dimitrios Mougiakakos, Johan Hansson, et al.
Zeitschrift Fur Rheumatologie|May 26, 2025
[Innovative treatments in rheumatology]Abhinav Singla, Christof Iking-Konert, Carolin Kellersmann, et al.
Plos One|January 27, 2026
Exploring innovative G-CSF schedules in AML cytarabine-based consolidation through a digital twin study of white blood cell recoveryAdrian-Manuel Reimann, Enrico Schalk, Dimitrios Mougiakakos, et al.
Biomarker Research|June 2, 2026
Unraveling the immune microenvironment in primary CNS lymphomaSven Lorenzen, Vanja Zeremski, Mirjeta Berisha, et al.
Plos One|June 16, 2015
Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROSMaarten A Ligtenberg, Özcan Çınar, Rikard Holmdahl, et al.
Stem Cells (Dayton, Ohio)|April 30, 2020
N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cellsVivien Strauch, Domenica Saul, Mirjeta Berisha, et al.
Advances in Cancer Research|July 15, 2009
Oxidative stress and lymphocyte persistence: implications in immunotherapyShikhar Mehrotra, Dimitrios Mougiakakos, C Christian Johansson, et al.
Oncotarget|March 24, 2018
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent mannerRomy Loschinski, Martin Böttcher, Andrej Stoll, et al.
Biomolecules|September 23, 2022
Lipotoxicity as a Barrier for T Cell-Based TherapiesRomy Böttcher-Loschinski, Judit Rial Saborido, Martin Böttcher, et al.
Pageof 16